MedTrace Logo

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine.

NCT07633067 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-06-08

No results posted yet for this study

Summary

This study is a multicenter, prospective, double-blind, multi-arm, randomized controlled trial that investigates whether middle meningeal artery embolization is superior to current standard pharmacotherapy for migraine. The main objectives of the study are to explore whether middle meningeal artery embolization can reduce migraine patients' dependence on migraine medications and to assess the safety of middle meningeal artery embolization with coils.

Conditions

Interventions

PROCEDURE

Middle meningeal artery embolization

Middle meningeal artery embolization with coils.

DRUG

Conventional standard pharmacotherapy for migraine

Conventional standard pharmacotherapy for migraine

Sponsors & Collaborators

  • Sichuan Action Medical Technology Co., Ltd.

    collaborator UNKNOWN

  • Juhui Medical Technology (Shenzhen) Co., Ltd.

    collaborator UNKNOWN

  • Beijing Xinke Medical Technology Co., Ltd.

    collaborator UNKNOWN

  • The Affiliated Hospital Of Guizhou Medical University

    lead OTHER

Principal Investigators

  • Zeguang Ren, MD. PhD. · The Affiliated Hospital Of Guizhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2028-12-31
Completion
2028-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07633067 on ClinicalTrials.gov